Literature DB >> 7911585

Genetic study of dopamine D1, D2, and D4 receptors in schizophrenia.

D Campion1, T d'Amato, C Bastard, C Laurent, F Guedj, M Jay, S Dollfus, F Thibaut, M Petit, P Gorwood.   

Abstract

The goal of this study was to define precisely the involvement of the dopamine D1, D2, and D4 receptor genes in the etiology of schizophrenia. A linkage analysis using the lod score method was performed in 37 families originating from France (n = 14) and from the Island of La Réunion in the Indian Ocean (n = 23). No evidence of linkage between schizophrenia and genetic markers located at these loci was found. A simulation study was carried out to gauge the significance of these results. The conclusions of a nonparametric linkage test (i.e., the affected pedigree member method) were equally negative. For each genetic marker, an allelic association with the disease was also sought: 80 unrelated patients and 80 healthy control subjects were tested, and no significant association was found. These results, which are in agreement with those obtained by other groups, do not support the involvement of the dopamine D1, D2, and D4 receptor genes in the pathogenesis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911585     DOI: 10.1016/0165-1781(94)90010-8

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  A search for association between schizophrenia and dopamine-related alleles.

Authors:  E Jönsson; S Brené; T Geijer; L Terenius; A Tylec; M L Persson; G Sedvall
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 2.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

3.  Genome-wide association study of multiplex schizophrenia pedigrees.

Authors:  Douglas F Levinson; Jianxin Shi; Kai Wang; Sang Oh; Brien Riley; Ann E Pulver; Dieter B Wildenauer; Claudine Laurent; Bryan J Mowry; Pablo V Gejman; Michael J Owen; Kenneth S Kendler; Gerald Nestadt; Sibylle G Schwab; Jacques Mallet; Deborah Nertney; Alan R Sanders; Nigel M Williams; Brandon Wormley; Virginia K Lasseter; Margot Albus; Stephanie Godard-Bauché; Madeline Alexander; Jubao Duan; Michael C O'Donovan; Dermot Walsh; Anthony O'Neill; George N Papadimitriou; Dimitris Dikeos; Wolfgang Maier; Bernard Lerer; Dominique Campion; David Cohen; Maurice Jay; Ayman Fanous; Peter Eichhammer; Jeremy M Silverman; Nadine Norton; Nancy Zhang; Hakon Hakonarson; Cynthia Gao; Ami Citri; Mark Hansen; Stephan Ripke; Frank Dudbridge; Peter A Holmans
Journal:  Am J Psychiatry       Date:  2012-09       Impact factor: 18.112

4.  Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis.

Authors:  Hairong He; Huanhuan Wu; Lihong Yang; Fan Gao; Yajuan Fan; Junqin Feng; Xiancang Ma
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-09       Impact factor: 2.570

5.  Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms.

Authors:  P A Holmans; B Riley; A E Pulver; M J Owen; D B Wildenauer; P V Gejman; B J Mowry; C Laurent; K S Kendler; G Nestadt; N M Williams; S G Schwab; A R Sanders; D Nertney; J Mallet; B Wormley; V K Lasseter; M C O'Donovan; J Duan; M Albus; M Alexander; S Godard; R Ribble; K Y Liang; N Norton; W Maier; G Papadimitriou; D Walsh; M Jay; A O'Neill; F B Lerer; D Dikeos; R R Crowe; J M Silverman; D F Levinson
Journal:  Mol Psychiatry       Date:  2009-02-17       Impact factor: 15.992

6.  Meta-analysis of 32 genome-wide linkage studies of schizophrenia.

Authors:  M Y M Ng; D F Levinson; S V Faraone; B K Suarez; L E DeLisi; T Arinami; B Riley; T Paunio; A E Pulver; P A Holmans; M Escamilla; D B Wildenauer; N M Williams; C Laurent; B J Mowry; L M Brzustowicz; M Maziade; P Sklar; D L Garver; G R Abecasis; B Lerer; M D Fallin; H M D Gurling; P V Gejman; E Lindholm; H W Moises; W Byerley; E M Wijsman; P Forabosco; M T Tsuang; H-G Hwu; Y Okazaki; K S Kendler; B Wormley; A Fanous; D Walsh; F A O'Neill; L Peltonen; G Nestadt; V K Lasseter; K Y Liang; G M Papadimitriou; D G Dikeos; S G Schwab; M J Owen; M C O'Donovan; N Norton; E Hare; H Raventos; H Nicolini; M Albus; W Maier; V L Nimgaonkar; L Terenius; J Mallet; M Jay; S Godard; D Nertney; M Alexander; R R Crowe; J M Silverman; A S Bassett; M-A Roy; C Mérette; C N Pato; M T Pato; J Louw Roos; Y Kohn; D Amann-Zalcenstein; G Kalsi; A McQuillin; D Curtis; J Brynjolfson; T Sigmundsson; H Petursson; A R Sanders; J Duan; E Jazin; M Myles-Worsley; M Karayiorgou; C M Lewis
Journal:  Mol Psychiatry       Date:  2008-12-30       Impact factor: 15.992

Review 7.  The role of C957T, TaqI and Ser311Cys polymorphisms of the DRD2 gene in schizophrenia: systematic review and meta-analysis.

Authors:  Thelma Beatriz González-Castro; Yazmín Hernández-Díaz; Isela Esther Juárez-Rojop; María Lilia López-Narváez; Carlos Alfonso Tovilla-Zárate; Alma Genis-Mendoza; Mariela Alpuin-Reyes
Journal:  Behav Brain Funct       Date:  2016-11-09       Impact factor: 3.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.